Key result
Non-contrast cardiac CT-derived left ventricular index was associated with increased coronary artery calcification in adjusted models (men: 14.6% increase, P=0.007; women: 17.4% increase, P=0.0002).
Why the study?
Is non-contrast cardiac CT-derived left ventricular index associated with cardiovascular risk factors and coronary artery calcification in a general population free of known cardiovascular disease?
Cohort (n=3,926)
Is non-contrast cardiac CT-derived left ventricular index associated with cardiovascular risk factors and coronary artery calcification in a general population free of known cardiovascular disease?
Effect estimate: 14.6% (men) and 17.4% (women) increase in CAC per 1 SD LVI (95% CI 3.7-26.6 (men); 7.8-27.8 (women))
p-value: p=0.007 (men); 0.0002 (women)
Non-contrast cardiac CT-derived left ventricular index is associated with body size, hypertension, and weakly linked with coronary artery calcium score in a general population.
Should not yet change risk assessment; leaves open whether LVI adds value beyond traditional factors for CAC prediction.
BACKGROUND: Increased left ventricular (LV) size is associated with cardiovascular mortality and morbidity. Once non-contrast cardiac computed tomography (CT) is performed for other purposes, information of LV size is readily available. PURPOSE: To determine the association of gated CT-derived LV size with cardiovascular risk factors and coronary artery calcification (CAC) and to describe age- and gender-specific normative values in a general population cohort. MATERIAL AND METHODS: LV area was quantified from non-contrast-enhanced CT in axial, end-diastolic images at a mid-ventricular slice in participants of the population-based Heinz Nixdorf Recall Study, free of known cardiovascular disease. LV index (LVI) was calculated by the quotient of LV area and body surface area (BSA). Crude and adjusted regression analyses were used to determine the association of LVI with risk factors and CAC. RESULTS: Overall, 3926 subjects (age 59 ± 8 years, 53% women) were included in this analysis. From quantification in end-diastolic phase, men had larger LV index (2232 ± 296 mm(2)/m(2) vs. 2088 ± 251 mm(2)/m(2), both P < 0.0001). LVI was strongly correlated systolic blood pressure (men, PE [95% CI]: 22.8 [15.5-30.2] mm(2)/10 mmHg; women, 23.4 [18.1-28.6]), and antihypertensive medication (men, 45.2 [14.7-75.8] mm(2); women: 46.5 [22.7-70.2], all P < 0.005). Cholesterol levels were associated with LVI in univariate analysis, however, correlations were low (R(2) ≤ 0.04). In multivariable regression, blood pressure, antihypertensive medication and cholesterol levels, remained associated with LVI (P < 0.05). LVI was linked with CAC in unadjusted (men, increase of CAC + 1 by 13.0% [1.4-25.8] with increased LVI by 1 standard deviation of LVI, P = 0.03; women, 20.7% [10.0-32.3], P < 0.0001) and risk factor adjusted models (men, 14.6% [3.7-26.6], P = 0.007); women, 17.4% [7.8-27.8], P = 0.0002). CONCLUSION: Non-contrast cardiac CT derived LV index is associated with body size and hypertension. LVI is weakly linked with CAC-score. Further studies need to evaluate whether assessment of LV dimensions from cardiac CT helps identifying subjects with increased cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Dykun et al. (2014) conducted a cohort in General population free of known cardiovascular disease (n=3,926). Left ventricular index (LVI) derived from non-contrast cardiac CT vs. Lower LVI was evaluated on Coronary artery calcification (CAC) (14.6% (men) and 17.4% (women) increase in CAC per 1 SD LVI, 95% CI 3.7-26.6 (men); 7.8-27.8 (women), p=0.007 (men); 0.0002 (women)). Non-contrast cardiac CT-derived left ventricular index was associated with increased coronary artery calcification in adjusted models (men: 14.6% increase, P=0.007; women: 17.4% increase, P=0.0002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: